Intellectual Property India Publishes Patent Application for 'Imidazotriazine Il-17a Modulators And Uses Thereof' Filed by Dice Alpha, Inc.

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517084495 A) filed by Dice Alpha, Inc., Indianapolis, on Sept. 5, for 'imidazotriazine il-17a modulators and uses thereof.'

Inventor(s) include Fatheree, Paul R.; Reilly, Maureen K.; Belabed, Hassane; Freidberg, Michael D; and Brandt, Gary Edward Lee.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "The disclosure herein provides lactam substituted imidazotriazine compounds or salts of Formula (I'), (I), (II), (II-a), (II-b), or (A), and pharmaceutical compositions thereof, for the modulation of IL-17A. These compounds are useful in the treatment of inflammatory conditions such as psoriasis."

The patent application was internationally filed on Feb. 09, 2024, under International application No.PCT/US2024/015156.

Disclaimer: Curated by HT Syndication.